Author Question: On which of the following pharmacological dimensions does cannabis (delta-9-THC) differ ... (Read 44 times)

scienceeasy

  • Hero Member
  • *****
  • Posts: 565
On which of the following pharmacological dimensions does cannabis (delta-9-THC) differ significantly from LSD, psilocybin and mescaline?
 
  a. the degree to which they induce profound and intense perceptual distortions and hallucinatory experiences
  b. their effects on wakefulness
  c. the rate at which tolerance develops to their subjective effects
  d. all of these

Question 2

The major psychoactive compound in marijuana, delta-9-THC, has actions mediated by CB1 receptors. An endogenous ligand for this class of receptors is called
 
  a. dopamine
  b. serotonin
  c. acetylcholine
  d. anandamide



xiaomengxian

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

d

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

The human body produces and destroys 15 million blood cells every second.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

Did you know?

Fungal nail infections account for up to 30% of all skin infections. They affect 5% of the general population—mostly people over the age of 70.

For a complete list of videos, visit our video library